184 related articles for article (PubMed ID: 36352097)
21. Mutation of
Su L; Zhang X; Zheng L; Wang M; Zhu Z; Li P
Front Endocrinol (Lausanne); 2020; 11():189. PubMed ID: 32373065
[No Abstract] [Full Text] [Related]
22. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.
Calvert AE; Chalastanis A; Wu Y; Hurley LA; Kouri FM; Bi Y; Kachman M; May JL; Bartom E; Hua Y; Mishra RK; Schiltz GE; Dubrovskyi O; Mazar AP; Peter ME; Zheng H; James CD; Burant CF; Chandel NS; Davuluri RV; Horbinski C; Stegh AH
Cell Rep; 2017 May; 19(9):1858-1873. PubMed ID: 28564604
[TBL] [Abstract][Full Text] [Related]
23. Chronic nickel (II) exposure induces the stemness properties of cancer cells through repressing isocitrate dehydrogenase (IDH1).
Wang L; He S; Xiong Z; Lu J; Lin Y; Jin H; Yang L
Ecotoxicol Environ Saf; 2021 Apr; 213():112031. PubMed ID: 33578097
[TBL] [Abstract][Full Text] [Related]
24. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
25. Low pH Facilitates Heterodimerization of Mutant Isocitrate Dehydrogenase IDH1-R132H and Promotes Production of 2-Hydroxyglutarate.
Sesanto R; Kuehn JF; Barber DL; White KA
Biochemistry; 2021 Jun; 60(25):1983-1994. PubMed ID: 34143606
[TBL] [Abstract][Full Text] [Related]
26. Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer.
Gonthier K; Poluri RTK; Weidmann C; Tadros M; Audet-Walsh É
Mol Cancer Res; 2019 Aug; 17(8):1699-1709. PubMed ID: 31068457
[TBL] [Abstract][Full Text] [Related]
27. Cancer-associated isocitrate dehydrogenase mutations inactivate NADPH-dependent reductive carboxylation.
Leonardi R; Subramanian C; Jackowski S; Rock CO
J Biol Chem; 2012 Apr; 287(18):14615-20. PubMed ID: 22442146
[TBL] [Abstract][Full Text] [Related]
28. NADP+ -dependent IDH1 R132 mutation and its relevance for glioma patient survival.
Baldewpersad Tewarie NM; Burgers IA; Dawood Y; den Boon HC; den Brok MG; Klunder JH; Koopmans KB; Rademaker E; van den Broek HB; van den Bersselaar SM; Witjes JJ; Van Noorden CJ; Atai NA
Med Hypotheses; 2013 Jun; 80(6):728-31. PubMed ID: 23541771
[TBL] [Abstract][Full Text] [Related]
29. Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin.
Biedermann J; Preussler M; Conde M; Peitzsch M; Richter S; Wiedemuth R; Abou-El-Ardat K; Krüger A; Meinhardt M; Schackert G; Leenders WP; Herold-Mende C; Niclou SP; Bjerkvig R; Eisenhofer G; Temme A; Seifert M; Kunz-Schughart LA; Schröck E; Klink B
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31888244
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma.
van Lith SA; Navis AC; Lenting K; Verrijp K; Schepens JT; Hendriks WJ; Schubert NA; Venselaar H; Wevers RA; van Rooij A; Wesseling P; Molenaar RJ; van Noorden CJ; Pusch S; Tops B; Leenders WP
Sci Rep; 2016 Jul; 6():30486. PubMed ID: 27460417
[TBL] [Abstract][Full Text] [Related]
31. An IDH1 mutation inhibits growth of glioma cells via GSH depletion and ROS generation.
Shi J; Zuo H; Ni L; Xia L; Zhao L; Gong M; Nie D; Gong P; Cui D; Shi W; Chen J
Neurol Sci; 2014 Jun; 35(6):839-45. PubMed ID: 24362902
[TBL] [Abstract][Full Text] [Related]
32. Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1.
Davis MI; Gross S; Shen M; Straley KS; Pragani R; Lea WA; Popovici-Muller J; DeLaBarre B; Artin E; Thorne N; Auld DS; Li Z; Dang L; Boxer MB; Simeonov A
J Biol Chem; 2014 May; 289(20):13717-25. PubMed ID: 24668804
[TBL] [Abstract][Full Text] [Related]
33. Novel Insights for Inhibiting Mutant Heterodimer IDH1
Juritz EI; Bascur JP; Almonacid DE; González-Nilo FD
Mol Diagn Ther; 2018 Jun; 22(3):369-380. PubMed ID: 29651790
[TBL] [Abstract][Full Text] [Related]
34. The roles of IDH1 in tumor metabolism and immunity.
Ni Y; Shen P; Wang X; Liu H; Luo H; Han X
Future Oncol; 2022 Nov; 18(35):3941-3953. PubMed ID: 36621781
[TBL] [Abstract][Full Text] [Related]
35. IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.
Izquierdo-Garcia JL; Viswanath P; Eriksson P; Cai L; Radoul M; Chaumeil MM; Blough M; Luchman HA; Weiss S; Cairncross JG; Phillips JJ; Pieper RO; Ronen SM
Cancer Res; 2015 Aug; 75(15):2999-3009. PubMed ID: 26045167
[TBL] [Abstract][Full Text] [Related]
36. Extracellular glutamate and IDH1
Tiburcio PDB; Gillespie DL; Jensen RL; Huang LE
J Neurooncol; 2020 Feb; 146(3):427-437. PubMed ID: 32020473
[TBL] [Abstract][Full Text] [Related]
37. Exploiting Electrode Nanoconfinement to Investigate the Catalytic Properties of Isocitrate Dehydrogenase (IDH1) and a Cancer-Associated Variant.
Herold RA; Reinbold R; Megarity CF; Abboud MI; Schofield CJ; Armstrong FA
J Phys Chem Lett; 2021 Jul; 12(26):6095-6101. PubMed ID: 34170697
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a Novel Chemical Scaffold Against Mutant Isocitrate Dehydrogenase 1 (IDH1).
Kang CH; Choi SU; Son YH; Lee HK; Jeong HG; Yun CS; Ahn S; Park CH
Anticancer Res; 2020 Sep; 40(9):4929-4935. PubMed ID: 32878781
[TBL] [Abstract][Full Text] [Related]
39. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism.
Grassian AR; Parker SJ; Davidson SM; Divakaruni AS; Green CR; Zhang X; Slocum KL; Pu M; Lin F; Vickers C; Joud-Caldwell C; Chung F; Yin H; Handly ED; Straub C; Growney JD; Vander Heiden MG; Murphy AN; Pagliarini R; Metallo CM
Cancer Res; 2014 Jun; 74(12):3317-31. PubMed ID: 24755473
[TBL] [Abstract][Full Text] [Related]
40. Wild-type IDH1 inhibition enhances chemotherapy response in melanoma.
Zarei M; Hajihassani O; Hue JJ; Graor HJ; Loftus AW; Rathore M; Vaziri-Gohar A; Asara JM; Winter JM; Rothermel LD
J Exp Clin Cancer Res; 2022 Sep; 41(1):283. PubMed ID: 36153582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
